BRPI0907831A2 - composição para modular o crescimento de célula-tronco com prostaglandinas - Google Patents

composição para modular o crescimento de célula-tronco com prostaglandinas

Info

Publication number
BRPI0907831A2
BRPI0907831A2 BRPI0907831A BRPI0907831A BRPI0907831A2 BR PI0907831 A2 BRPI0907831 A2 BR PI0907831A2 BR PI0907831 A BRPI0907831 A BR PI0907831A BR PI0907831 A BRPI0907831 A BR PI0907831A BR PI0907831 A2 BRPI0907831 A2 BR PI0907831A2
Authority
BR
Brazil
Prior art keywords
composition
stem cell
cell growth
modulating prostaglandin
prostaglandin
Prior art date
Application number
BRPI0907831A
Other languages
English (en)
Portuguese (pt)
Inventor
Ueno Ryuji
Kuno Sachiko
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of BRPI0907831A2 publication Critical patent/BRPI0907831A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/134—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings monocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0907831A 2008-02-19 2009-02-19 composição para modular o crescimento de célula-tronco com prostaglandinas BRPI0907831A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2971308P 2008-02-19 2008-02-19
PCT/JP2009/053474 WO2009104807A1 (en) 2008-02-19 2009-02-19 Composition for modulating stem cell growth with prostaglandins

Publications (1)

Publication Number Publication Date
BRPI0907831A2 true BRPI0907831A2 (pt) 2017-04-11

Family

ID=40602552

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907831A BRPI0907831A2 (pt) 2008-02-19 2009-02-19 composição para modular o crescimento de célula-tronco com prostaglandinas

Country Status (16)

Country Link
US (2) US8871752B2 (https=)
EP (2) EP2303278A1 (https=)
JP (1) JP2011512323A (https=)
KR (1) KR20100119803A (https=)
CN (2) CN104248638A (https=)
AR (1) AR073158A1 (https=)
AU (1) AU2009216067B2 (https=)
BR (1) BRPI0907831A2 (https=)
CA (1) CA2715486A1 (https=)
IL (1) IL207652A0 (https=)
MX (1) MX2010009131A (https=)
NZ (1) NZ587348A (https=)
RU (1) RU2010138603A (https=)
TW (1) TW200942614A (https=)
WO (1) WO2009104807A1 (https=)
ZA (1) ZA201006125B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010108028A2 (en) * 2009-03-19 2010-09-23 Fate Therapeutics, Inc. Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same
US8569279B2 (en) 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
EP2435049A1 (en) * 2009-05-27 2012-04-04 Sucampo AG Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders
KR101171912B1 (ko) 2010-11-29 2012-08-07 기아자동차주식회사 밸브브릿지 일체형 가변 밸브 액츄에이터
EP2785350B1 (en) 2011-12-02 2018-05-02 Fate Therapeutics, Inc. Improved methods of treating ischemia
JP6220791B2 (ja) 2011-12-02 2017-10-25 フェイト セラピューティクス，インコーポレイテッド 増強された幹細胞組成物
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
WO2014150602A1 (en) 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
US20140371304A1 (en) * 2013-06-13 2014-12-18 Sucampo Ag Method for suppressing tumorigenicity of stem cells
US9918994B2 (en) 2016-03-04 2018-03-20 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for muscle regeneration using prostaglandin E2
JP2019513010A (ja) * 2016-03-04 2019-05-23 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー プロスタグランジンｅ２を用いる、筋再生のための組成物および方法
WO2018227138A1 (en) 2017-06-09 2018-12-13 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for preventing or treating muscle conditions
RU2686718C1 (ru) * 2018-03-12 2019-04-30 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Средство, стимулирующее функции мезенхимальных клеток-предшественников in vitro

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5221763A (en) * 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
TW224942B (https=) * 1990-04-04 1994-06-11 Adka Ueno Kk
EP0503887B1 (en) * 1991-03-14 1996-08-28 R-Tech Ueno Ltd. Promotion of wound-healing with 15-keto-prostaglandin compounds
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
US5703108A (en) * 1996-02-28 1997-12-30 Pfizer Inc. Bone deposition by certain prostaglandin agonists
JP3187438B2 (ja) * 1996-06-10 2001-07-11 株式会社アールテック・ウエノ エンドセリン拮抗剤
EP1267882B1 (en) 2000-03-24 2009-04-15 Sucampo AG Prostaglandins for the treatment of eye disease caused by light irradiation like photoretinitis
DK1841433T3 (da) 2005-01-27 2012-01-16 Sucampo Ag Præparat til behandling af lidelser i centralnervesystemet
JP4557288B2 (ja) * 2005-01-28 2010-10-06 アイシン・エィ・ダブリュ株式会社 画像認識装置及び画像認識方法、並びにそれを用いた位置特定装置、車両制御装置及びナビゲーション装置
DE602006018583D1 (de) * 2005-03-04 2011-01-13 Sucampo Ag Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
AU2006326853B2 (en) 2005-12-22 2012-02-16 Es Cell International Pte Ltd Direct differentiation of cardiomyocytes from human embryonic stem cells
RU2425876C2 (ru) 2006-03-24 2011-08-10 Чилдрен'З Медикал Сентер Корпорейшн Способ модулирования роста гематопоэтических стволовых клеток
EP2094839B1 (en) 2006-12-08 2020-02-05 University of Rochester Expansion of hematopoietic stem cells
EP2114411A2 (en) * 2007-02-27 2009-11-11 Sucampo AG Composition and method for protecting mitochondria
FI20075417A0 (fi) * 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen

Also Published As

Publication number Publication date
US20090209643A1 (en) 2009-08-20
CN102014921A (zh) 2011-04-13
AR073158A1 (es) 2010-10-20
AU2009216067B2 (en) 2014-02-13
TW200942614A (en) 2009-10-16
WO2009104807A1 (en) 2009-08-27
NZ587348A (en) 2012-04-27
ZA201006125B (en) 2011-05-25
CA2715486A1 (en) 2009-08-27
IL207652A0 (en) 2010-12-30
US8871752B2 (en) 2014-10-28
EP2303278A1 (en) 2011-04-06
RU2010138603A (ru) 2012-03-27
US20150005381A1 (en) 2015-01-01
CN104248638A (zh) 2014-12-31
KR20100119803A (ko) 2010-11-10
JP2011512323A (ja) 2011-04-21
AU2009216067A1 (en) 2009-08-27
MX2010009131A (es) 2010-12-06
EP2656845A1 (en) 2013-10-30

Similar Documents

Publication Publication Date Title
BRPI0907831A2 (pt) composição para modular o crescimento de célula-tronco com prostaglandinas
EP2400926A4 (en) MITRAL FLAP SET WITH ATRIAL ANCHOR
IL228818A (en) Compounds Stabilize Stem Cell Culture
BRPI0809974A2 (pt) Compostos de pirimidina hidrazida como inibidores de pgds
ZA200906574B (en) Method to modulate hematopoietic stem cell growth
ZA201000199B (en) Algae growth for biofuels
LT4306158T (lt) Protezinis vožtuvas mitralinio vožtuvo pakeitimui
DK3192865T3 (da) Enkelt pluripotent stamcelle-kultur
GB2458863B (en) Improved culture of stem cells
EP2349097A4 (en) IMPROVED ARTIFICIAL HEARTLAP
EP2349095C0 (en) IMPROVED ARTIFICIAL HEART VALVE
DK3572100T3 (da) Sammensætning til stimulering af epitelcellevækst
IL212368A0 (en) Compounds that expand hematopoietic stem cells
DK2300013T4 (da) Phosphorderivater som kinasehæmmere
BRPI0920135A2 (pt) imidazopiridazinacarbonitrilos úteis como inibidores de quinase
BRPI0820054A2 (pt) Uso de bactérias para a produção de bioenergia
BRPI0917104A2 (pt) Métodos para aperfeiçoamento do crescimento de plantas
BR112012012292A2 (pt) composição esporicida para esporos de clostridium difficile
EP2501238A4 (en) PEST CONTROL COMPOSITION
BRPI0913925A2 (pt) Diferenciação de células-tronco pluripotentes
EP2464226A4 (en) PEST CONTROL COMPOSITION
BRPI0910059A2 (pt) Composição sólida para controle de praga
DK2370456T3 (da) Ekspressionskassetter til frøspecifik ekspression i planter
BRPI0921165A2 (pt) Composição para controle de desenvolvimento de plantas
EP2331676A4 (en) GROWTH FACTOR OF A HEMATOPOIETIC STEM CELL

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]